CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 44 filers reported holding CTI BIOPHARMA CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $27,449,831 | -7.4% | 6,535,674 | +32.5% | 9.21% | -26.2% |
Q4 2022 | $29,653,941 | -10.1% | 4,934,100 | -13.0% | 12.48% | -15.9% |
Q3 2022 | $32,996,000 | +50.1% | 5,669,388 | +54.0% | 14.83% | +45.1% |
Q2 2022 | $21,977,000 | +0.5% | 3,681,195 | -21.4% | 10.22% | +12.7% |
Q1 2022 | $21,876,000 | +0.2% | 4,684,404 | -46.8% | 9.07% | -9.4% |
Q4 2021 | $21,825,000 | -7.1% | 8,800,358 | +10.5% | 10.02% | -6.3% |
Q3 2021 | $23,495,000 | +23.1% | 7,964,329 | +4.3% | 10.69% | +7.1% |
Q2 2021 | $19,081,000 | +99.1% | 7,632,530 | +131.8% | 9.98% | +92.7% |
Q1 2021 | $9,584,000 | +44.9% | 3,293,419 | +60.3% | 5.18% | +2.3% |
Q4 2020 | $6,614,000 | -18.4% | 2,054,000 | -45.5% | 5.06% | -39.9% |
Q3 2020 | $8,102,000 | +71.7% | 3,768,597 | -7.4% | 8.43% | -7.8% |
Q2 2020 | $4,719,000 | -20.2% | 4,068,191 | -36.7% | 9.14% | +46.1% |
Q1 2020 | $5,916,000 | -0.3% | 6,430,637 | +71.3% | 6.26% | +51.3% |
Q4 2019 | $5,933,000 | +91.0% | 3,755,000 | +1.2% | 4.14% | +37.1% |
Q3 2019 | $3,107,000 | -7.4% | 3,711,999 | -4.9% | 3.02% | +30.6% |
Q2 2019 | $3,355,000 | -13.6% | 3,904,400 | -2.4% | 2.31% | +3.5% |
Q1 2019 | $3,881,000 | -7.6% | 4,000,000 | -30.2% | 2.23% | -39.5% |
Q4 2018 | $4,201,000 | -63.3% | 5,726,579 | +8.0% | 3.69% | -44.9% |
Q3 2018 | $11,452,000 | -43.2% | 5,302,063 | +30.9% | 6.70% | -45.4% |
Q2 2018 | $20,166,000 | +0.6% | 4,049,298 | -21.2% | 12.25% | +14.0% |
Q1 2018 | $20,053,000 | +307.8% | 5,141,746 | +180.2% | 10.74% | +264.6% |
Q4 2017 | $4,917,000 | +55.2% | 1,834,838 | +84.8% | 2.95% | +57.8% |
Q3 2017 | $3,168,000 | -58.1% | 993,000 | -56.5% | 1.87% | -54.3% |
Q2 2017 | $7,561,000 | – | 2,284,381 | – | 4.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|